Inactive Instrument

SMITH & NEPHEW Share Price Swiss Exchange

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

End-of-day quote Swiss Exchange
- GBX - Intraday chart for SMITH & NEPHEW
Sales 2024 * 5.81B 454B Sales 2025 * 6.12B 478B Capitalization 11.8B 922B
Net income 2024 * 526M 41.07B Net income 2025 * 687M 53.64B EV / Sales 2024 * 2.48 x
Net Debt 2024 * 2.61B 204B Net Debt 2025 * 2.3B 179B EV / Sales 2025 * 2.3 x
P/E ratio 2024 *
21.3 x
P/E ratio 2025 *
16.1 x
Employees -
Yield 2024 *
2.76%
Yield 2025 *
3.09%
Free-Float 99.15%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 31/03/22
Director of Finance/CFO 56 11-30
Compliance Officer - 31/03/99
Members of the board TitleAgeSince
Director/Board Member 65 30/09/17
Director/Board Member 62 13/09/23
Chairman 63 25/04/23
More insiders
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
Calendar
More about the company